US Stock MarketDetailed Quotes

SXTP 60 Degrees Pharmaceuticals

Watchlist
  • 1.090
  • +0.080+7.92%
Close Nov 27 16:00 ET
  • 1.080
  • -0.010-0.92%
Post 17:16 ET
2.03MMarket Cap-564P/E (TTM)

60 Degrees Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
55.20%-1.68M
-279.03%-1.19M
-176.35%-1.14M
-349.80%-4.54M
3.50%-63.67K
-1,122.26%-3.75M
41.34%-313.49K
-302.38%-412.68K
-55.60%-1.01M
78.82%-65.98K
Net income from continuing operations
-151.77%-2.16M
-24.84%-4.17M
116.48%427.99K
38.27%-3.81M
-22.55%-2.05M
387.70%4.17M
-55.51%-3.34M
-186.25%-2.6M
-45.01%-6.18M
-22.32%-1.67M
Operating gains losses
-81.04%56.71K
-99.72%1.1K
-306.01%-1.74M
323.21%1.67M
199.06%132.6K
1,229.64%299.1K
--391.76K
--845.02K
--394.24K
---133.87K
Depreciation and amortization
-42.36%14.66K
-55.95%11.01K
-16.50%22.13K
27.40%100.37K
9.51%23.44K
30.87%25.43K
30.67%24.99K
40.85%26.5K
9.75%78.79K
16.46%21.41K
Other non cash items
----
----
----
-484.52%-4.48M
-1,617.49%-5.22M
-94.34%27.3K
51.73%334.31K
217.46%375.27K
92.67%1.16M
42.32%343.73K
Change In working capital
89.57%-263.99K
-75.07%221.24K
-97.76%16.55K
-87.97%405.36K
7.96%1.31M
-463.68%-2.53M
6.64%887.52K
17.46%739.48K
16.33%3.37M
60.47%1.21M
-Change in receivables
-118.93%-27.45K
146.58%19.85K
-130.11%-84.89K
-284.63%-185.37K
-162.60%-93.32K
91.34%-12.54K
-133.20%-42.62K
-14.16%-36.89K
-85.92%100.4K
-37.30%149.08K
-Change in inventory
-143.77%-26.02K
-91.40%9.36K
128.49%30.79K
2,001.00%212.75K
227.76%152.54K
188.97%59.44K
641.08%108.84K
-193.14%-108.08K
-96.76%10.13K
-4.34%46.54K
-Change in prepaid assets
82.79%-254.27K
273.12%92.67K
243.18%61.84K
-2,197.70%-522.37K
3,084.26%990.21K
-2,445.27%-1.48M
-137.40%-53.53K
166.76%18.02K
-81.67%24.9K
-292.92%-33.18K
-Change in payables and accrued expense
104.62%43.74K
-88.80%99.36K
-97.32%22.45K
-63.21%1.05M
-67.44%272.26K
-211.90%-947.34K
103.09%887.02K
13.91%838.68K
65.70%2.86M
104.98%836.06K
-Change in other current liabilities
--0
--0
-11.46%-13.65K
-7.43%-50.27K
-5.01%-13.15K
-5.00%-12.67K
-5.00%-12.21K
-15.76%-12.25K
-17.52%-46.8K
-425.12%-12.52K
-Change in other working capital
----
----
----
-123.52%-100K
--0
-422.66%-140K
--0
--40K
722.07%425.26K
389.21%226.1K
Cash from discontinued investing activities
Operating cash flow
55.20%-1.68M
-279.03%-1.19M
-176.35%-1.14M
-349.80%-4.54M
3.50%-63.67K
-1,122.26%-3.75M
41.34%-313.49K
-302.38%-412.68K
-55.60%-1.01M
78.82%-65.98K
Investing cash flow
Cash flow from continuing investing activities
-6,158.80%-1.75M
-620.25%-130.56K
-198.12%-9.81K
-92.72%-115.89K
-13.50%-66.56K
-2,066.67%-27.91K
-771.07%-18.13K
-298.55%-3.29K
-69.91%-60.13K
-3,243.50%-58.65K
Capital expenditure reported
-56.30%-21.57K
-127.36%-27.57K
77.95%-726
-20.93%-39.98K
65.92%-10.76K
-1,072.59%-13.8K
-482.75%-12.13K
-298.55%-3.29K
-2.29%-33.06K
-1,700.17%-31.58K
Net PPE purchase and sale
-655.51%-13.77K
----
----
---57.62K
---55.8K
---1.82K
----
----
--0
--0
Net intangibles purchase and sale
73.14%-3.3K
-116.45%-12.99K
---9.09K
32.46%-18.28K
--0
---12.28K
---6K
--0
---27.07K
---27.07K
Cash from discontinued investing activities
Investing cash flow
-6,158.80%-1.75M
-620.25%-130.56K
-198.12%-9.81K
-92.72%-115.89K
-13.50%-66.56K
-2,066.67%-27.91K
-771.07%-18.13K
-298.55%-3.29K
-69.91%-60.13K
-3,243.50%-58.65K
Financing cash flow
Cash flow from continuing financing activities
-13.75%5.15M
-100.27%-865
943.54%1.9M
429.96%6.47M
0
5.97M
-75.12%321.07K
182.39K
99.88%1.22M
-181.85%-68.63K
Net issuance payments of debt
--0
----
----
-186.98%-961.11K
--0
---1.61M
----
----
80.78%1.11M
--0
Net common stock issuance
-18.97%5.23M
--0
--1.91M
--6.45M
--0
--6.45M
--0
--0
--0
---185.34K
Proceeds from stock option exercised by employees
--0
--5K
--5K
--1.13M
--0
--1.13M
--0
--0
--0
--0
Net other financing activities
-1,963.98%-80K
98.22%-5.86K
-108.89%-16.22K
-228.89%-150.42K
--0
---3.88K
---328.93K
--182.39K
--116.71K
----
Cash from discontinued financing activities
Financing cash flow
-13.75%5.15M
-100.27%-865
943.54%1.9M
429.96%6.47M
--0
--5.97M
-75.12%321.07K
--182.39K
99.88%1.22M
-181.85%-68.63K
Net cash flow
Beginning cash position
8,167.45%1.58M
9,551.25%2.89M
708.90%2.14M
129.52%264.87K
404.91%2.22M
--19.07K
-72.37%29.99K
129.52%264.87K
-39.80%115.4K
30.95%439.39K
Current changes in cash
-21.36%1.72M
-12,409.58%-1.32M
422.39%753.04K
1,097.79%1.82M
32.61%-130.23K
--2.19M
---10.55K
-125.94%-233.58K
306.89%151.59K
15.75%-193.25K
Effect of exchange rate changes
-80.97%1.78K
511.23%1.54K
36.12%-824
3,007.99%61.85K
189.35%54.18K
245.58%9.34K
99.66%-374
-101.34%-1.29K
29.83%-2.13K
103.07%18.72K
End cash Position
48.78%3.3M
8,167.45%1.58M
9,551.25%2.89M
708.90%2.14M
708.90%2.14M
--2.22M
--19.07K
-72.37%29.99K
129.52%264.87K
129.52%264.87K
Free cash flow
54.51%-1.72M
-297.68%-1.32M
-176.52%-1.15M
-335.36%-4.66M
-4.50%-130.23K
-1,137.07%-3.78M
38.19%-331.62K
-302.35%-415.97K
-56.34%-1.07M
60.21%-124.62K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 55.20%-1.68M-279.03%-1.19M-176.35%-1.14M-349.80%-4.54M3.50%-63.67K-1,122.26%-3.75M41.34%-313.49K-302.38%-412.68K-55.60%-1.01M78.82%-65.98K
Net income from continuing operations -151.77%-2.16M-24.84%-4.17M116.48%427.99K38.27%-3.81M-22.55%-2.05M387.70%4.17M-55.51%-3.34M-186.25%-2.6M-45.01%-6.18M-22.32%-1.67M
Operating gains losses -81.04%56.71K-99.72%1.1K-306.01%-1.74M323.21%1.67M199.06%132.6K1,229.64%299.1K--391.76K--845.02K--394.24K---133.87K
Depreciation and amortization -42.36%14.66K-55.95%11.01K-16.50%22.13K27.40%100.37K9.51%23.44K30.87%25.43K30.67%24.99K40.85%26.5K9.75%78.79K16.46%21.41K
Other non cash items -------------484.52%-4.48M-1,617.49%-5.22M-94.34%27.3K51.73%334.31K217.46%375.27K92.67%1.16M42.32%343.73K
Change In working capital 89.57%-263.99K-75.07%221.24K-97.76%16.55K-87.97%405.36K7.96%1.31M-463.68%-2.53M6.64%887.52K17.46%739.48K16.33%3.37M60.47%1.21M
-Change in receivables -118.93%-27.45K146.58%19.85K-130.11%-84.89K-284.63%-185.37K-162.60%-93.32K91.34%-12.54K-133.20%-42.62K-14.16%-36.89K-85.92%100.4K-37.30%149.08K
-Change in inventory -143.77%-26.02K-91.40%9.36K128.49%30.79K2,001.00%212.75K227.76%152.54K188.97%59.44K641.08%108.84K-193.14%-108.08K-96.76%10.13K-4.34%46.54K
-Change in prepaid assets 82.79%-254.27K273.12%92.67K243.18%61.84K-2,197.70%-522.37K3,084.26%990.21K-2,445.27%-1.48M-137.40%-53.53K166.76%18.02K-81.67%24.9K-292.92%-33.18K
-Change in payables and accrued expense 104.62%43.74K-88.80%99.36K-97.32%22.45K-63.21%1.05M-67.44%272.26K-211.90%-947.34K103.09%887.02K13.91%838.68K65.70%2.86M104.98%836.06K
-Change in other current liabilities --0--0-11.46%-13.65K-7.43%-50.27K-5.01%-13.15K-5.00%-12.67K-5.00%-12.21K-15.76%-12.25K-17.52%-46.8K-425.12%-12.52K
-Change in other working capital -------------123.52%-100K--0-422.66%-140K--0--40K722.07%425.26K389.21%226.1K
Cash from discontinued investing activities
Operating cash flow 55.20%-1.68M-279.03%-1.19M-176.35%-1.14M-349.80%-4.54M3.50%-63.67K-1,122.26%-3.75M41.34%-313.49K-302.38%-412.68K-55.60%-1.01M78.82%-65.98K
Investing cash flow
Cash flow from continuing investing activities -6,158.80%-1.75M-620.25%-130.56K-198.12%-9.81K-92.72%-115.89K-13.50%-66.56K-2,066.67%-27.91K-771.07%-18.13K-298.55%-3.29K-69.91%-60.13K-3,243.50%-58.65K
Capital expenditure reported -56.30%-21.57K-127.36%-27.57K77.95%-726-20.93%-39.98K65.92%-10.76K-1,072.59%-13.8K-482.75%-12.13K-298.55%-3.29K-2.29%-33.06K-1,700.17%-31.58K
Net PPE purchase and sale -655.51%-13.77K-----------57.62K---55.8K---1.82K----------0--0
Net intangibles purchase and sale 73.14%-3.3K-116.45%-12.99K---9.09K32.46%-18.28K--0---12.28K---6K--0---27.07K---27.07K
Cash from discontinued investing activities
Investing cash flow -6,158.80%-1.75M-620.25%-130.56K-198.12%-9.81K-92.72%-115.89K-13.50%-66.56K-2,066.67%-27.91K-771.07%-18.13K-298.55%-3.29K-69.91%-60.13K-3,243.50%-58.65K
Financing cash flow
Cash flow from continuing financing activities -13.75%5.15M-100.27%-865943.54%1.9M429.96%6.47M05.97M-75.12%321.07K182.39K99.88%1.22M-181.85%-68.63K
Net issuance payments of debt --0---------186.98%-961.11K--0---1.61M--------80.78%1.11M--0
Net common stock issuance -18.97%5.23M--0--1.91M--6.45M--0--6.45M--0--0--0---185.34K
Proceeds from stock option exercised by employees --0--5K--5K--1.13M--0--1.13M--0--0--0--0
Net other financing activities -1,963.98%-80K98.22%-5.86K-108.89%-16.22K-228.89%-150.42K--0---3.88K---328.93K--182.39K--116.71K----
Cash from discontinued financing activities
Financing cash flow -13.75%5.15M-100.27%-865943.54%1.9M429.96%6.47M--0--5.97M-75.12%321.07K--182.39K99.88%1.22M-181.85%-68.63K
Net cash flow
Beginning cash position 8,167.45%1.58M9,551.25%2.89M708.90%2.14M129.52%264.87K404.91%2.22M--19.07K-72.37%29.99K129.52%264.87K-39.80%115.4K30.95%439.39K
Current changes in cash -21.36%1.72M-12,409.58%-1.32M422.39%753.04K1,097.79%1.82M32.61%-130.23K--2.19M---10.55K-125.94%-233.58K306.89%151.59K15.75%-193.25K
Effect of exchange rate changes -80.97%1.78K511.23%1.54K36.12%-8243,007.99%61.85K189.35%54.18K245.58%9.34K99.66%-374-101.34%-1.29K29.83%-2.13K103.07%18.72K
End cash Position 48.78%3.3M8,167.45%1.58M9,551.25%2.89M708.90%2.14M708.90%2.14M--2.22M--19.07K-72.37%29.99K129.52%264.87K129.52%264.87K
Free cash flow 54.51%-1.72M-297.68%-1.32M-176.52%-1.15M-335.36%-4.66M-4.50%-130.23K-1,137.07%-3.78M38.19%-331.62K-302.35%-415.97K-56.34%-1.07M60.21%-124.62K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data